Generex Biotechnology Corp. (GNBT) OTC MARKETS
$0 - (-)
Market Cap: $73235
As of 10/27/22 12:00 AM EDT. Market closed.
Generex Biotechnology Corp. (GNBT)
OTC MARKETS
$0
- (-)
Market Cap: $73235
As of 10/27/22 12:00 AM EDT. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Joseph Moscato
Full Time Employees
14
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Joseph Moscato
Full Time Employees
14
URL
Address
10102 USA Today Way, Florida, Miramar, 33025-3903.
PRICE CHART FOR GENEREX BIOTECHNOLOGY CORP
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0
Days Range
$0 - $0
52 week range
$0 - $0.16
Volume
0
Avg. Volume (30 days)
13,879
Market Cap
$73235
Dividend Yield
-
P/E
-
Shares Outstanding
122,058,444
Open
-
Previous Close
$0
Days Range
$0 - $0
52 week range
$0 - $0.16
Volume
0
Avg. Volume (30 days)
13,879
Market Cap
$73235
Dividend Yield
-
P/E
-
Shares Outstanding
122,058,444
FINANCIAL STATEMENTS FOR GENEREX BIOTECHNOLOGY CORP
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR GENEREX BIOTECHNOLOGY CORP
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Haines Harold Gray | Consultant | Dec 04, 2018 | Buy | $2.11 | 1,500 | 3,169 | 945 | Dec 14, 2018, 02:31 PM |
| Haines Harold Gray | Consultant | Dec 07, 2018 | Buy | $1.05 | 8,300 | 8,709 | 8,000 | Dec 14, 2018, 12:18 PM |
| Brusegard David | Chief Operating Officer | Feb 16, 2016 | Option Exercise | $0.00 | 1,667,671 | 1,668 | 5,615,070 | Feb 16, 2016, 05:03 PM |
| FLETCHER MARK | President & CEO | Feb 16, 2016 | Option Exercise | $0.00 | 4,447,111 | 4,447 | 15,821,836 | Feb 16, 2016, 05:02 PM |
| Brusegard David | Chief Operating Officer | Feb 09, 2016 | Option Exercise | $0.00 | 5,583,775 | 5,584 | 3,916,104 | Feb 12, 2016, 04:10 PM |
| FLETCHER MARK | President & CEO | Feb 09, 2016 | Option Exercise | $0.00 | 14,890,033 | 14,890 | 10,442,992 | Feb 12, 2016, 04:08 PM |
| BARRATT JOHN P | Director | Apr 27, 2015 | Option Exercise | $0.00 | 5,874,162 | 5,874 | 5,874,162 | Apr 27, 2015, 04:00 PM |
| FLETCHER MARK | President & CEO | Oct 06, 2014 | Option Exercise | $0.00 | 470,726 | 471 | 470,726 | Oct 08, 2014, 03:38 PM |
| BARRATT JOHN P | Director | Oct 06, 2014 | Option Exercise | $0.00 | 35,714 | 36 | 35,714 | Oct 08, 2014, 03:31 PM |
| MCGEE BRIAN | Director | Oct 06, 2014 | Option Exercise | $0.00 | 35,714 | 36 | 35,714 | Oct 08, 2014, 03:26 PM |
| FELLOWS STEPHEN | Chief Financial Officer | Jun 18, 2013 | Sale | $0.04 | 2,524,164 | 89,608 | 0 | Jun 20, 2013, 04:00 PM |
| FELLOWS STEPHEN | Chief Financial Officer | Jun 06, 2013 | Option Exercise | $0.00 | 2,524,164 | 2,524 | 2,524,164 | Jun 10, 2013, 04:35 PM |
| Masterson Nola E | Director | Jul 03, 2012 | Option Exercise | $0.00 | 508,197 | 508 | 508,197 | Jul 05, 2012, 04:34 PM |
| FELLOWS STEPHEN | Acting Chief Financial Officer | Jun 25, 2012 | Sale | $0.09 | 546,448 | 50,383 | 0 | Jun 27, 2012, 04:09 PM |
| FELLOWS STEPHEN | Acting Chief Financial Officer | Jun 21, 2012 | Option Exercise | $0.00 | 546,448 | 546 | 546,448 | Jun 21, 2012, 07:19 PM |
| PERRI ROSE C | Director | May 09, 2011 | Sale | $0.23 | 15,000 | 3,450 | 975,478 | May 11, 2011, 10:35 AM |
| PERRI ROSE C | Director | May 06, 2011 | Sale | $0.22 | 20,000 | 4,500 | 990,478 | May 09, 2011, 05:01 PM |
| PERRI ROSE C | Director | May 03, 2011 | Sale | $0.22 | 25,000 | 5,500 | 1,010,478 | May 04, 2011, 09:51 PM |
| FLETCHER MARK | See Remarks | Apr 06, 2011 | Buy | $0.24 | 20,000 | 4,780 | 286,077 | Apr 07, 2011, 09:58 AM |
| PERRI ROSE C | COO, CFO& Treas. | Jan 03, 2011 | Option Exercise | $0.00 | 576,752 | 577 | 1,035,478 | Jan 03, 2011, 05:18 PM |
| PERRI ROSE C | COO, CFO& Treas. | Oct 27, 2010 | Buy | $0.35 | 54,000 | 18,900 | 458,726 | Oct 27, 2010, 04:01 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Haines Harold Gray | Consultant | 12/04/2018 | 3,169 |
| Haines Harold Gray | Consultant | 12/07/2018 | 8,709 |
| Brusegard David | Chief Operating Officer | 02/16/2016 | 1,668 |
| FLETCHER MARK | President & CEO | 02/16/2016 | 4,447 |
| Brusegard David | Chief Operating Officer | 02/09/2016 | 5,584 |
| FLETCHER MARK | President & CEO | 02/09/2016 | 14,890 |
| BARRATT JOHN P | Director | 04/27/2015 | 5,874 |
| FLETCHER MARK | President & CEO | 10/06/2014 | 471 |
| BARRATT JOHN P | Director | 10/06/2014 | 36 |
| MCGEE BRIAN | Director | 10/06/2014 | 36 |
| FELLOWS STEPHEN | Chief Financial Officer | 06/18/2013 | 89,608 |
| FELLOWS STEPHEN | Chief Financial Officer | 06/06/2013 | 2,524 |
| Masterson Nola E | Director | 07/03/2012 | 508 |
| FELLOWS STEPHEN | Acting Chief Financial Officer | 06/25/2012 | 50,383 |
| FELLOWS STEPHEN | Acting Chief Financial Officer | 06/21/2012 | 546 |
| PERRI ROSE C | Director | 05/09/2011 | 3,450 |
| PERRI ROSE C | Director | 05/06/2011 | 4,500 |
| PERRI ROSE C | Director | 05/03/2011 | 5,500 |
| FLETCHER MARK | See Remarks | 04/06/2011 | 4,780 |
| PERRI ROSE C | COO, CFO& Treas. | 01/03/2011 | 577 |
| PERRI ROSE C | COO, CFO& Treas. | 10/27/2010 | 18,900 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR GENEREX BIOTECHNOLOGY CORP
LOADING...